<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
    <channel>
        <title>PR.com Press Releases: AnaSpec, Inc. News</title>
        <description>Latest news releases from PR.com for AnaSpec, Inc.</description>
        <link>http://www.pr.com/press-releases</link>
        <lastBuildDate>Wed, 19 Nov 2008 05:07:46 -0500</lastBuildDate>
        <image>
            <url>http://www.pr.com/images/logo_white.jpg</url>
            <title>Press Releases from PR.com</title>
            <link>http://www.pr.com/</link>
            <width>68</width>
            <height>69</height>
            <description>PR.com provides Free Press Release Distribution, &amp; is a unique Directory of Businesses, Products, Services, &amp; Jobs - in all industries.  Find Full Company Profiles.</description>
        </image>
        <copyright>© 2008 PR Worldwide, Inc.</copyright>
        <ttl>60</ttl>
        <item>
            <title>AnaSpec Establishes New Dedicated GMP Manufacturing Facility</title>
            <link>http://www.pr.com/press-release/116914</link>
            <description>In response to increased demand for GMP peptide production, AnaSpec has established a new facility dedicated to GMP manufacturing. Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5000 sq. ft. of dedicated GMP space including two class 10,000 clean rooms.

&amp;ldquo;The need for GMP-grade peptides is growing,&amp;rdquo; stated AnaSpec CEO, Dr. Frank Hong. &amp;ldquo;The [PR.com - November 16, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/116914</guid>
        </item>
        <item>
            <title>AnaSpec Introduces Series of Luminescent and Non-Luminescent Calcium Indicators</title>
            <link>http://www.pr.com/press-release/116527</link>
            <description>AnaSpec offers coelenterazine and several synthetic coelenterazine analogs for reconstituting aequorin in cells that have been transfected with apoaequorin cDNA. [PR.com - November 14, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/116527</guid>
        </item>
        <item>
            <title>AnaSpec Introduces Improved AnaTagTM APC, B-PE and R-PE Labeling Kits</title>
            <link>http://www.pr.com/press-release/115919</link>
            <description>AnaSpec is pleased to announce the release of the improved AnaTagTM APC, B-PE and R-PE Labeling Kits.

Labeling of antibodies can be both tedious and time-consuming. Without the use of proper techniques and reagents, the conjugation may result in suboptimal or no labeling. AnaSpec&amp;rsquo;s improved APC, B-PE and R-PE Labeling Kits contain all the reagents needed for optimized labeling of antibodies. The phycobiliproteins, [PR.com - November 12, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/115919</guid>
        </item>
        <item>
            <title>AnaSpec Introduces Fluorescent Calcium Indicators</title>
            <link>http://www.pr.com/press-release/114642</link>
            <description>Calcium plays a vital role in the regulation of cardiac contractility, growth and gene expression; consequently, calcium measurement is critical in numerous biological investigations. Fluorescent probes that show spectral responses upon Ca2+ binding have enabled researchers to investigate changes in intracellular free Ca2+ concentrations using techniques such as fluorescence microscopy, flow cytometry, fluorescence [PR.com - November 05, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/114642</guid>
        </item>
        <item>
            <title>AnaSpec Introduces New PKD1 &amp; PKD2 Antibodies</title>
            <link>http://www.pr.com/press-release/112353</link>
            <description>Protein kinase D (PKD belongs to the calcium calmodulin superfamily of kinases (2-3). [PR.com - October 23, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/112353</guid>
        </item>
        <item>
            <title>AnaSpec Introduces New SensoLyteTM MMP ELISA Kits</title>
            <link>http://www.pr.com/press-release/111529</link>
            <description>MMPs are key players in normal and pathological processes, including embryogenesis, wound healing, inflammation, arthritis, and cancer. [PR.com - October 18, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/111529</guid>
        </item>
        <item>
            <title>AnaSpec’s FRET Feature Article Available at Photonics.com</title>
            <link>http://www.pr.com/press-release/111013</link>
            <description>AnaSpec published a technical article entitled, “Sensitive FRET Assays Aid Drug Discovery” in the August edition of Biophotonics International. [PR.com - October 16, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/111013</guid>
        </item>
        <item>
            <title>AnaSpec Introduces Histone GO™ Peptides - Acetylated &amp; Methylated</title>
            <link>http://www.pr.com/press-release/110273</link>
            <description>The core histones (H2A, H2B, H3 and H4) act as spools around which DNA winds. Covalent modification on the amino terminal of the core histones through de/acetylation, de/methylation and de/phosphorylation affect chromatin structure and exquisitely regulate gene expression.1-3 Histone hyperacetylation is correlated with increased transcription, whereas hypoacetylation correlates with transcriptional repression.2
AnaSpec, [PR.com - October 11, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/110273</guid>
        </item>
        <item>
            <title>TBTA - Click Chemistry Ligand for Cu (I)</title>
            <link>http://www.pr.com/press-release/107103</link>
            <description>Copper (I) species are powerful catalysts for the formation of 1,2,3-triazoles from azides and alkynes. The general thermodynamic instability of Cu(I) however, results in easy oxidation to Cu(II) and/or disproportionation to Cu(0) and Cu(II).1 TBTA, Tris-[(1-benzyl-1H-1,2,3-triazol-4-yl) methyl]amine, also known as tris-(benzyltriazolylmethyl)amine, is a stabilizing ligand for Cu(I) developed by Tim Chan in [PR.com - September 24, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/107103</guid>
        </item>
        <item>
            <title>AnaSpec Celebrates 15 Year Anniversary</title>
            <link>http://www.pr.com/press-release/106717</link>
            <description>Since its inception in 1993, AnaSpec has provided drug discovery reagents to some of the world’s largest biotech, pharmaceutical, and academic research institutions. [PR.com - September 21, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/106717</guid>
        </item>
        <item>
            <title>AnaSpec to Manufacture BD™ Fluorescent Dyes for BD Biosciences</title>
            <link>http://www.pr.com/press-release/106279</link>
            <description>AnaSpec announced today that BD Biosciences, a business segment of BD (Becton Dickinson and Company), has chosen it to manufacture and supply the BD&amp;trade; H7, Calcein AM and DiIC12(3) Fluorescent Dyes.

&amp;ldquo;BD Biosciences has a tremendous reputation in the industry for innovative products of the highest quality,&amp;rdquo; stated Dr. Anita Hong, AnaSpec&amp;rsquo;s president. &amp;ldquo;We are proud to leverage AnaSpec&amp;rsquo;s [PR.com - September 19, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/106279</guid>
        </item>
        <item>
            <title>AnaSpec Introduces High Performance Labeled Streptavidins</title>
            <link>http://www.pr.com/press-release/105971</link>
            <description>AnaSpec has introduced its latest collection of streptavidins labeled with its patented HiLyte Fluor(TM) and HiLytePlus(TM) dyes which promise brighter fluorescence and better photostability compared to FITC and Cyâ dyes. [PR.com - September 18, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/105971</guid>
        </item>
        <item>
            <title>RayBiotech and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes</title>
            <link>http://www.pr.com/press-release/105710</link>
            <description>AnaSpec and RayBiotech today announced a licensing agreement that will allow RayBiotech to label antibodies with AnaSpec HiLytePlus&amp;trade; and HiLyte Fluor&amp;trade; dyes and integrate into protein and antibody arrays.

HiLytePlus&amp;trade; and HiLyte Fluor&amp;trade; are AnaSpec's proprietary series of high performance fluorescent dyes optimized for long wavelength biomarker labeling.

&amp;quot;RayBiotech is a respected provider of [PR.com - September 17, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/105710</guid>
        </item>
        <item>
            <title>AnaSpec and Cyclex Sign Licensing Agreement for Deacetylase Activity Assay Kits</title>
            <link>http://www.pr.com/press-release/105367</link>
            <description>AnaSpec and Cyclex Co. Ltd. today announced a licensing agreement that will allow AnaSpec to make, use, and sell deacetylase activity assay kits and the related products as covered by Cyclex&amp;rsquo;s patent # &amp;lsquo;s EP 1243658, US 7033778, US 7256013.

&amp;quot;We are pleased to partner with Cyclex in expanding our array of next generation assay kits,&amp;quot; noted Dr. Anita Hong, AnaSpec's president. &amp;quot;The new [PR.com - September 14, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/105367</guid>
        </item>
        <item>
            <title>AnaSpec Introduces Kinase Substrates as GO™ Peptides</title>
            <link>http://www.pr.com/press-release/104733</link>
            <description>Protein kinases are a transferase family of self-regulatory enzymes that catalyze the phosphorylation of other proteins by covalently attaching phosphate groups to them, using ATP as a phosphate donor. Reversible protein phosphorylation-dephosphorylation has a principal role in the regulation of essentially all cellular functions and most aspects of cell life, and phosphorylation by protein kinases is a major signal [PR.com - September 11, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/104733</guid>
        </item>
        <item>
            <title>Recombinant MOG Proteins - New</title>
            <link>http://www.pr.com/press-release/104535</link>
            <description>Expanding on its world-class collection of MOG peptides and assay kits, AnaSpec is pleased to announce the release of 3 MOG recombinant proteins, for human, mouse and rat.

These proteins, with sequences corresponding to human, mouse and rat extracellular domain, together with a 6x His tag were expressed in E. coli and purified from urea denatured bacterial lysate. The molecular weight found in all 3 recombinant proteins [PR.com - September 10, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/104535</guid>
        </item>
        <item>
            <title>AnaSpec Peptides Used in Latest Alzheimer’s Research Findings by VU University Medical Centre and Lund University</title>
            <link>http://www.pr.com/press-release/102983</link>
            <description>At the 2008 International Conference for Alzheimer&amp;rsquo;s Disease, the VU University Medical Centre and Lund University presented a joint poster entitled, &amp;ldquo;A&amp;beta;1-42 binding and uptake by primary human astrocytes in vitro: Effects of a1-Antichymotrypsin.&amp;rdquo; The authors of the study were H. M Nielsen, S. Janciauskiene, B. Holmqvist, and R. Veerhuis.

The A&amp;beta;1-42 peptides that were a key ingredient in the [PR.com - August 31, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/102983</guid>
        </item>
        <item>
            <title>New Anti-GHSR Antibodies from AnaSpec</title>
            <link>http://www.pr.com/press-release/102801</link>
            <description>AnaSpec has announced the release of two antibodies for growth secretagogue receptor (GHSR). One antibody targets the N-terminus and the other an internal sequence.

GHSR is a G protein-coupled receptor with seven transmembrane domains and is primarily expressed in hypothalamus and pituitary glands (1-4).

GHSR gene is located on chromosome 3q26.31 and results in two products: functional 366 amino acids long GSHR1a and [PR.com - August 30, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/102801</guid>
        </item>
        <item>
            <title>AnaSpec and UW TechTransfer Sign Licensing Agreement for Protein Tyrosine Phosphatases</title>
            <link>http://www.pr.com/press-release/102601</link>
            <description>AnaSpec and UW TechTransfer today announced a licensing agreement that will allow AnaSpec to make, use, and sell Protein Tyrosine Phosphatase Substrates as covered by UW&amp;rsquo;s patent # 5,739,278 entitled &amp;ldquo;Compositions for Protein Tyrosine Phosphatases.&amp;rdquo;

&amp;quot;We are pleased to partner with UW TechTransfer to provide our customers with one of the largest selections of research-ready peptides in the [PR.com - August 29, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/102601</guid>
        </item>
        <item>
            <title>Biocore and AnaSpec Sign Distributor Agreement</title>
            <link>http://www.pr.com/press-release/100256</link>
            <description>AnaSpec and Biocore Pty Ltd today announced a non-exclusive distributor agreement that will allow Biocore Pty Ltd to distribute AnaSpec&amp;rsquo;s catalog and custom products throughout Australia.

AnaSpec&amp;rsquo;s Director of Sales &amp;amp; Marketing, Violeta Rajkovska, noted, &amp;ldquo;AnaSpec is pleased to partner with Biocore to make our products available to the vibrant research community in Australia. We look forward to a [PR.com - August 14, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/100256</guid>
        </item>
        <item>
            <title>AnaSpec Introduces GO Peptides™ - Research-Ready Peptides on Demand</title>
            <link>http://www.pr.com/press-release/100055</link>
            <description>AnaSpec is pleased to introduce GO Peptides™, the next evolution in peptide tools. [PR.com - August 13, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/100055</guid>
        </item>
        <item>
            <title>AnaSpec Introduces New SensoLyte™ 570 Generic MMP Assay Kit with Industry’s Highest Wavelength</title>
            <link>http://www.pr.com/press-release/99553</link>
            <description>Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated proteins capable of digesting extracellular matrix components. The importance of MMPs in tumor development and invasion as well as other diseases is well known.

AnaSpec has introduced the SensoLyteTM 570 Generic MMP Assay Kit, offering the industry&amp;rsquo;s highest emission wavelength for MMP detection. The higher emission wavelength [PR.com - August 09, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/99553</guid>
        </item>
        <item>
            <title>Novus Biologicals and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes</title>
            <link>http://www.pr.com/press-release/97668</link>
            <description>AnaSpec and Novus Biologicals today announced a licensing agreement that will allow Novus Biologicals to label Novus antibodies with AnaSpec HiLytePlus&amp;trade; and HiLyte Fluor&amp;trade; dyes.

HiLytePlus&amp;trade; and HiLyte Fluor&amp;trade; are AnaSpec's proprietary series of high performance fluorescent dyes optimized for long wavelength biomarker labeling.

&amp;quot;Novus Biologicals has established a strong reputation in the [PR.com - July 30, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/97668</guid>
        </item>
        <item>
            <title>AnaSpec Offers Custom Peptide-Aminoluciferin Synthesis</title>
            <link>http://www.pr.com/press-release/96550</link>
            <description>AnaSpec now offers custom synthesis service of peptide-aminoluciferin substrates. [PR.com - July 23, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/96550</guid>
        </item>
        <item>
            <title>AnaSpec Introduces New Series of PAR Peptides</title>
            <link>http://www.pr.com/press-release/94067</link>
            <description>AnaSpec has introduced its latest series of PAR peptides. [PR.com - July 09, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/94067</guid>
        </item>
        <item>
            <title>New Anti-Keratin Antibodies Introduced by AnaSpec</title>
            <link>http://www.pr.com/press-release/93427</link>
            <description>AnaSpec has introduced two keratin antibodies that recognize both the intact and caspase digested N-terminal of K18 and K19 at Asp237. These antibodies are useful tools for studying keratin dynamics in mice undergoing hepatocyte apoptosis, patients with cirrhosis, and also in apoptotic cells of various epithelial human tumors in a non-invasive manner.

Intermediate filaments (IFs), together with actin microfilaments and [PR.com - July 04, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/93427</guid>
        </item>
        <item>
            <title>New SensoLyte HDAC Assay Kit Introduced by AnaSpec</title>
            <link>http://www.pr.com/press-release/92317</link>
            <description>Histone deacetylase (HDAC) enzymes modulate gene expression through the deacetylation of lysine residues on histone proteins and act as transcriptional repressors of genes. Based on their role in cell cycling, apoptosis and differentiation, HDACs have been chosen as therapeutic targets for the treatment of cancer and neurodegenerative diseases.

AnaSpec has introduced the SensoLyte&amp;trade; 520 HDAC Activity Assay Kit, a [PR.com - June 27, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/92317</guid>
        </item>
        <item>
            <title>AnaSpec Offers Custom Synthesis of Hydrocarbon-Stapled Peptides</title>
            <link>http://www.pr.com/press-release/91239</link>
            <description>The innovative technique of hydrocarbon stapling in peptides is introducing valuable new functionality to peptide-related research. AnaSpec is pleased to offer custom synthesis for hydrocarbon-stapled peptides.

Hydrocarbon-stapled peptides are peptides capable of forming stable alpha helical structure as a result of &amp;ldquo;hydrocarbon stapling.&amp;rdquo;1,2 Many biological pathways, such as signal transduction, occur [PR.com - June 20, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/91239</guid>
        </item>
        <item>
            <title>New Anti-CARMA Antibody Series Released by AnaSpec</title>
            <link>http://www.pr.com/press-release/90907</link>
            <description>AnaSpec has introduced a new series of IHC validated antibodies, Anti-CARMA/CARD/Bimp antibodies.

CARMA proteins are scaffold molecules that belong to the membrane-associated guanylate kinase-like (MAGUK) and the caspase-associated recruitment domain (CARD) protein families. They play critical role in antigen receptor signaling pathways.1-4 CARMA-1 (CARD-11) CARMA-2 (CARD-14), and CARMA-3 (CARD-10) share homologous [PR.com - June 19, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/90907</guid>
        </item>
        <item>
            <title>AnaSpec Introduces Eleven New Peptides</title>
            <link>http://www.pr.com/press-release/90653</link>
            <description>This week AnaSpec, a world leader in custom and catalog peptides, introduced eleven (11) new peptides. [PR.com - June 18, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/90653</guid>
        </item>
        <item>
            <title>New SensoLyte™ 520 Cathepsin S Assay Kit Introduced by AnaSpec</title>
            <link>http://www.pr.com/press-release/87400</link>
            <description>AnaSpec has introduced the SensoLyte™ 520 Cathepsin S Assay Kit to its broad collection of long wavelength FRET protease assay kits. [PR.com - May 29, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/87400</guid>
        </item>
        <item>
            <title>AnaSpec Introduces Sixty New Peptides &amp; 3 New Assay Kits</title>
            <link>http://www.pr.com/press-release/86992</link>
            <description>This week, AnaSpec introduced sixty (60) new catalog peptides and three (3) new assay kits. [PR.com - May 27, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/86992</guid>
        </item>
        <item>
            <title>AnaSpec Introduces 8 New Antibody Products</title>
            <link>http://www.pr.com/press-release/86877</link>
            <description>AnaSpec added eight (8) new antibody products to its growing collection. [PR.com - May 24, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/86877</guid>
        </item>
        <item>
            <title>AnaSpec Introduces ClearPoint™ Heavy Isotope-Labeled Peptides</title>
            <link>http://www.pr.com/press-release/85926</link>
            <description>AnaSpec has introduced ClearPoint™ Peptides, heavy isotope-labeled peptides for absolute quantitation (AQUA) of proteins. [PR.com - May 18, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/85926</guid>
        </item>
        <item>
            <title>AnaSpec’s Published References Passes 600</title>
            <link>http://www.pr.com/press-release/83723</link>
            <description>The number of published papers that cite AnaSpec’s products has passed 600. [PR.com - May 04, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/83723</guid>
        </item>
        <item>
            <title>AnaSpec Presents Fluorimetric TACE Detection Poster at SBS Conference</title>
            <link>http://www.pr.com/press-release/83613</link>
            <description>AnaSpec presented its latest findings in regards to the detection of TACE activity using FRET technology. [PR.com - May 03, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/83613</guid>
        </item>
        <item>
            <title>AnaSpec Introduces a Suite of Phospho-Specific Anti-Her2 Antibodies</title>
            <link>http://www.pr.com/press-release/82971</link>
            <description>AnaSpec has introduced a full suite of phospho-specific ErbB-2 (Her-2) polyclonal antibodies. [PR.com - April 30, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/82971</guid>
        </item>
        <item>
            <title>AnaSpec Introduces 13 New Antibody Products</title>
            <link>http://www.pr.com/press-release/82344</link>
            <description>AnaSpec added thirteen (13) new antibody products to its growing collection. [PR.com - April 25, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/82344</guid>
        </item>
        <item>
            <title>SensoLyte™ MMP Assay Kits Offer a New Industry Standard for Sensitivity</title>
            <link>http://www.pr.com/press-release/82088</link>
            <description>AnaSpec’s SensoLyte™ line of MMP assay kits have quickly become the new standard in MMP assay sensitivity. [PR.com - April 24, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/82088</guid>
        </item>
        <item>
            <title>AnaSpec FRET-Based MMP Substrates Used in Double Differential in Vivo Zymography</title>
            <link>http://www.pr.com/press-release/81937</link>
            <description>AnaSpec FRET-based MMP substrates were recently used in a double differential in vivo zymography study at the University of New Brunswick. [PR.com - April 23, 2008]</description>
            <author>AnaSpec, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/81937</guid>
        </item>
    </channel>
</rss>
